DAWN vs JD · rev $131.2M vs P/E 7.6, $45.56B cap
Day One Biopharmaceuticals Inc (DAWN) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
JD does not have a complete income-statement cache yet.
DAWN currently screens at market cap $656.8M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the DAWN and JD stock pages for the full models.
Not investment advice.